US Patent 7169888 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity

Patent 7169888 was granted and assigned to Abbott on January, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Abbott

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71698880

Patent Inventor Names

Michael F. Bradley0

Fortuna Haviv0

Date of Patent

January 30, 2007

Patent Application Number

102835490

Date Filed

October 30, 2002

Patent Primary Examiner

‌

Cecilia J. Tsang

Patent abstract

Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7169888 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API